Ausgabe 10/2011
Inhalt (14 Artikel)
Combination of targeted therapy and immunotherapy in melanoma
Christian U. Blank, Anna I. Hooijkaas, John B. Haanen, Ton N. Schumacher
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
Anna Maria Berghella, Patrizia Pellegrini, Tiziana Del Beato, Fabiana Ciccone, Ida Contasta
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma
Laura Alaniz, Manglio Rizzo, Mariana G. Garcia, Flavia Piccioni, Jorge B. Aquino, Mariana Malvicini, Catalina Atorrasagasti, Juan Bayo, Itziar Echeverria, Pablo Sarobe, Guillermo Mazzolini
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers
Goki Shindo, Takayoshi Endo, Masamitsu Onda, Yoju Miyamoto, Toru Kaneko, Shigenori Goto
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Häusler, Itsaso Montalbán del Barrio, Jenny Strohschein, P. Anoop Chandran, Jörg B. Engel, Arnd Hönig, Monika Ossadnik, Evi Horn, Birgitt Fischer, Mathias Krockenberger, Stefan Heuer, Ahmed Adel Seida, Markus Junker, Hermann Kneitz, Doris Kloor, Karl-Norbert Klotz, Johannes Dietl, Jörg Wischhusen
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass, Nicola E. Annels, Deborah D. Stocken, Hardev A. Pandha, Gary W. Middleton
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
Mladen Korbelik, Wei Zhang, Soroush Merchant
An ADP ribosylation factor-GTPase activating protein negatively regulates the production of proinflammatory mediators in response to lipopolysaccharide
Abedul Haque, Abu Shadat Mohammod Noman, Naoki Koide, Erdenezaya Odkhuu, Yoshikazu Naiki, Shoji Hashimoto, Takayuki Komatsu, Tomoaki Yoshida, Takashi Yokochi
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang, Mahazarin R. Kaikobad, Marianne Wallace, Mary Jane Staab, Dorothea L. Horvath, George Wilding, Glenn Liu, Jens C. Eickhoff, Douglas G. McNeel, Miroslav Malkovsky
Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors
Diana L. Thomas, Rosalinda Doty, Vesna Tosic, Jia Liu, David M. Kranz, Grant McFadden, Amy L. MacNeill, Edward J. Roy
Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity
Manjunatha Ankathatti Munegowda, Yulin Deng, Sean J. Mulligan, Jim Xiang
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
Fabio Morandi, Maria Valeria Corrias, Isabella Levreri, Paola Scaruffi, Lizzia Raffaghello, Barbara Carlini, Paola Bocca, Ignazia Prigione, Sara Stigliani, Loredana Amoroso, Soldano Ferrone, Vito Pistoia
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
Runbo Zhong, Jiajun Teng, Baohui Han, Hua Zhong
The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure
Romina Molinari, Donatella D’Eliseo, Laura Manzi, Lello Zolla, Francesca Velotti, Nicolò Merendino